| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a77e13517c8f611a0a40a1af3c1788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_072b4744a6c226225cf4b0f2ed526920
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3571fecb831292024381c07c237b2c1b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-03 |
| filingDate |
2009-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38f85970feacd8ef2cd826814701a34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1932b0e07352268a1c081a96d411d725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50a153c5b385e14e3485a3b71a227751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4290280b44e8b8075c93a203f3a008a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed8b64430a0946f54641f0f64b785e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b661007a373af82544f2e770531b3be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67f104eb47b37fd91e8362cc1636134b |
| publicationDate |
2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2400164-C1 |
| titleOfInvention |
Method of treating rhinophyma |
| abstract |
FIELD: medicine. ^ SUBSTANCE: invention refers to otorhinolaryngology and can be applied for treating rhynophyma. Rhinophyma nodes are excised by a stretched string electrode in the tip Parus of the electric destruction apparatus Photec-80. Hypertrophied skin areas are cut in layers to be uniformly covered with the amorphous powder Bismuth Subgallate to form on the surface a layer of thickness 1-3 mm. 6-8 days after the operation, Bepanthen ointment is applied for 17-20 days. In the postoperative period, Phlebodia is administered for 60 days. ^ EFFECT: method allows reducing traumatism and risk of recurrence. ^ 1 ex, 3 dwg |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2492834-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2727695-C1 |
| priorityDate |
2009-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |